Skip to main content Help with accessibility Skip to main navigation

LIRAGLUTIDE injection (Saxenda®) for managing overweight and obesity

CCG Approval Status:

Date Added: 28 - Jan - 2021
Body System:
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of LIRAGLUTIDE injection (Saxenda®), by specialists only, for managing overweight and obesity within a Tier 3 secondary care weight management service, in accordance with NICE TA664.